Why Oncocyte Shot 13% Higher Today

What happenedCancer diagnostics specialist Oncocyte (NYSEMKT: OCX) rose at a double-digit pace on Friday on news that it’s tapping the stock market for a new round of capital-raising.Read MoreMarketsMarkets Feed

¡Haz clic para votar esta entrada!
(Votos: 0 Promedio: 0)

Deja un comentario